CY1324A - Antibacterial compositions containing chlorhexidine - Google Patents
Antibacterial compositions containing chlorhexidine Download PDFInfo
- Publication number
- CY1324A CY1324A CY1324A CY132480A CY1324A CY 1324 A CY1324 A CY 1324A CY 1324 A CY1324 A CY 1324A CY 132480 A CY132480 A CY 132480A CY 1324 A CY1324 A CY 1324A
- Authority
- CY
- Cyprus
- Prior art keywords
- chlorhexidine
- pharmaceutically acceptable
- salt
- acid
- microorganism
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/24—Y being a hetero atom
- C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
- C07C279/265—X and Y being nitrogen atoms, i.e. biguanides containing two or more biguanide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
- C07C57/10—Sorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3834—Aromatic acids (P-C aromatic linkage)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3359379A | 1979-04-26 | 1979-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1324A true CY1324A (en) | 1986-06-27 |
Family
ID=21871298
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY1324A CY1324A (en) | 1979-04-26 | 1980-04-25 | Antibacterial compositions containing chlorhexidine |
| CY1316A CY1316A (en) | 1979-04-26 | 1980-04-25 | Chlorhexidine salts and compositions of same |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY1316A CY1316A (en) | 1979-04-26 | 1980-04-25 | Chlorhexidine salts and compositions of same |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS55149242A (enExample) |
| AT (1) | AT373235B (enExample) |
| CA (1) | CA1159834A (enExample) |
| CH (2) | CH648755A5 (enExample) |
| CY (2) | CY1324A (enExample) |
| DE (1) | DE3016110A1 (enExample) |
| ES (1) | ES490947A0 (enExample) |
| FR (1) | FR2455034A1 (enExample) |
| GB (2) | GB2053195B (enExample) |
| HK (2) | HK1486A (enExample) |
| IT (1) | IT1188929B (enExample) |
| MY (2) | MY8600498A (enExample) |
| NL (1) | NL8002483A (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050058673A1 (en) | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
| US8476319B2 (en) | 2005-03-10 | 2013-07-02 | 3M Innovative Properties Company | Methods of treating ear infections |
| BRPI0608691A2 (pt) | 2005-03-10 | 2010-12-07 | 3M Innovative Properties Company | composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição |
| CA2599653A1 (en) | 2005-03-10 | 2006-09-21 | 3M Innovative Properties Company | Methods of reducing microbial contamination |
| WO2011061272A2 (en) * | 2009-11-18 | 2011-05-26 | Medichem S.A. | A di(4-chloro-phenyldiguanido) derivative which is free of potential genotoxicity and a process for reducing the residual amount of p-chloroaniline in said di(4-chloro-phenyldiguanido) derivative |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB815800A (en) * | 1956-06-06 | 1959-07-01 | Ici Ltd | New biguanide salts |
| US2684924A (en) * | 1951-02-05 | 1954-07-27 | Ici Ltd | Nu-chlorophenyldiguanidino compounds |
| US2990425A (en) * | 1956-06-06 | 1961-06-27 | Ici Ltd | New biguanide salts |
| US3159537A (en) * | 1960-12-20 | 1964-12-01 | American Cyanamid Co | Potentiation of tetracycline by phosphinic acid |
| BE612641A (enExample) * | 1961-01-18 | |||
| US3694447A (en) * | 1970-03-10 | 1972-09-26 | Smith Kline French Lab | Complexes of phosphanilic acid and 9-amino-3-nitroacridine |
| US3794723A (en) * | 1970-03-10 | 1974-02-26 | Smithkline Corp | Complexes of phosphanilic acid and 9-amino-3-nitroacridine useful as antifungal or antibacterial agents |
| SE370003B (enExample) * | 1971-05-18 | 1974-09-30 | Kema Nord Ab | |
| GB1338003A (en) * | 1971-06-18 | 1973-11-21 | Ici Ltd | Cleaning compositions |
| SE374658B (enExample) * | 1972-07-31 | 1975-03-17 | Hesselgren S G | |
| US3976765A (en) * | 1973-11-01 | 1976-08-24 | Colgate-Palmolive Company | Antibacterial oral preparations |
| US4125610A (en) * | 1977-07-27 | 1978-11-14 | Bristol-Myers Company | Antibacterial compositions |
-
1980
- 1980-04-23 CA CA000350482A patent/CA1159834A/en not_active Expired
- 1980-04-24 IT IT48512/80A patent/IT1188929B/it active
- 1980-04-25 FR FR8009398A patent/FR2455034A1/fr active Granted
- 1980-04-25 CH CH3086/84A patent/CH648755A5/de not_active IP Right Cessation
- 1980-04-25 ES ES490947A patent/ES490947A0/es active Granted
- 1980-04-25 CH CH322480A patent/CH646948A5/de not_active IP Right Cessation
- 1980-04-25 CY CY1324A patent/CY1324A/en unknown
- 1980-04-25 JP JP5439280A patent/JPS55149242A/ja active Pending
- 1980-04-25 DE DE19803016110 patent/DE3016110A1/de active Granted
- 1980-04-25 GB GB8013786A patent/GB2053195B/en not_active Expired
- 1980-04-25 CY CY1316A patent/CY1316A/en unknown
- 1980-04-28 NL NL8002483A patent/NL8002483A/nl not_active Application Discontinuation
- 1980-04-28 AT AT0227880A patent/AT373235B/de not_active IP Right Cessation
-
1982
- 1982-10-13 GB GB08229195A patent/GB2118041B/en not_active Expired
-
1986
- 1986-01-09 HK HK14/86A patent/HK1486A/xx unknown
- 1986-03-27 HK HK212/86A patent/HK21286A/xx unknown
- 1986-12-30 MY MY498/86A patent/MY8600498A/xx unknown
- 1986-12-30 MY MY495/86A patent/MY8600495A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB2053195A (en) | 1981-02-04 |
| CH646948A5 (de) | 1984-12-28 |
| HK21286A (en) | 1986-04-04 |
| CA1159834A (en) | 1984-01-03 |
| JPS55149242A (en) | 1980-11-20 |
| DE3016110C2 (enExample) | 1990-12-13 |
| DE3016110A1 (de) | 1980-11-06 |
| IT8048512A0 (it) | 1980-04-24 |
| MY8600495A (en) | 1986-12-31 |
| GB2118041A (en) | 1983-10-26 |
| IT1188929B (it) | 1988-01-28 |
| NL8002483A (nl) | 1980-10-28 |
| GB2053195B (en) | 1983-04-07 |
| IT8048512A1 (it) | 1981-10-24 |
| FR2455034B1 (enExample) | 1984-08-10 |
| FR2455034A1 (fr) | 1980-11-21 |
| CY1316A (en) | 1986-03-28 |
| ATA227880A (de) | 1983-05-15 |
| GB2118041B (en) | 1984-03-21 |
| HK1486A (en) | 1986-01-17 |
| ES8105259A1 (es) | 1981-05-16 |
| MY8600498A (en) | 1986-12-31 |
| AT373235B (de) | 1983-12-27 |
| CH648755A5 (de) | 1985-04-15 |
| ES490947A0 (es) | 1981-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4666896A (en) | Chlorhexidine salts and compositions of same | |
| DE69113604T2 (de) | Quinoloncarbonsäurederivat. | |
| GB2079270A (en) | Imidazo-rifamycin derivatives | |
| US5747484A (en) | Crystalline cepham acid addition salts and processes for their preparation | |
| GB2064513A (en) | Cephalosporin antibiotic | |
| CY1324A (en) | Antibacterial compositions containing chlorhexidine | |
| EP0237495B1 (en) | Halogenides of the ester of 2,n,n,n-dimethyl-alkyl-amino-ethanol with substituted acetic acid and pharmaceutical compositions having antiinflammatory and antiseptic activities containing same | |
| US3707482A (en) | Carbamate derivatives of 2h-pyran-3(6h)-one | |
| CA1166155A (en) | Method for inhibiting the growth of a microorganism on an inanimate substrate | |
| CA1148863A (en) | Chlorhexidine salts and compositions of same | |
| US4141968A (en) | Novel salts of 1,3-bis-(β-ethylhexyl)-5-amino-5-methyl-hexahydropyrimidine in compositions having bacteriostatic activity | |
| DE2629926A1 (de) | Clavulansaeureamide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate | |
| JPS63165381A (ja) | ［３ｓ（ｚ）］−２−［［［１−（２−アミノ−４−チアゾリル）−２−［［２，２−ジメチル−４−オキソ−１−（スルホオキシ）−３−アゼチジニル］アミノ］−２−オキソエチリデン］アミノ］オキシ］酢酸の結晶塩 | |
| US5142076A (en) | Metallo-organic salt compounds and pharmaceutical uses thereof | |
| US4226808A (en) | 1-Aryl-2-dihalogenodeuterioalkanoylamido-1,3-propanediol antibacterial agents | |
| US5556879A (en) | Aqueous spectinomycin borate solutions | |
| US3324003A (en) | Method of controlling growth of bacteria using 4-methyl-1-benzo[f]quinolone-2-carboxylic acid | |
| US4142050A (en) | Salts of 1,3-bis(β-ethylhexyl)-5-amino-5-methyl-hexahydropyrimidine | |
| US3574209A (en) | Quaternary ammonium salts of methenamine | |
| IE49930B1 (en) | Water-soluble hydrazones of 3-formylrifamycin sv | |
| AT405180B (de) | Neue derivate von substituierten 3-cephem-4-carbonsäurederivaten und verfahren zu deren herstellung | |
| CA1175356A (en) | Chlorhexidine salts and compositions of same | |
| CA2214327C (en) | Aqueous spectinomycin borate solutions | |
| US7001886B2 (en) | Hot melt method for preparing diphenhydramine tannate | |
| HU176077B (en) | Process for preparing terephtalic acid monoamide derivatives |